Clinical Value Analysis of Montelukast Sodium in the Treatment of Cough Variant Asthma in Children
Objective To explore the effect of montelukast sodium treatment on the recurrence and quality of life of cough variant asthma(CVA)in children.Methods A total of 96 children with cough-variant asthma from Zhuhai Center for Maternal and Child Health Care,from March 2020 to March 2022,were divide into two groups based on different admission orders,with 48 cases in each group.The control group received routine treatment,while the intervention group received combined with montelukast sodium under conventional treatment conditions.The treatment effectiveness,cough status,lung function,quality of life,and CVA recurrence between the two groups were compared.Results The effective rate of the intervention group was 93.8%,while the effective rate of the control group was 83.4%.The effective rate of the study group was higher than that of the control group(P<0.05).The intervention group had lower daytime and nighttime cough scores(P<0.05).The intervention group had higher lung function(P<0.05).The intervention group had higher quality of life(P<0.05).The intervention group had less recurrence of CVA(P<0.05).The recurrence rate of CVA in the intervention group was 2.1%,while in the control group it was 14.6%.The recurrence rate in the intervention group was lower than that in the control group(χ2=7.512,P<0.05).Conclusion Montelukast sodium in the treatment of children with cough variant asthma can obtain relatively good clinical efficacy,can further reduce the risk of disease recurrence in children,improve the prognosis,and has high application value.
monelukast sodiumchildren with cough variant asthmarecurrencequality of lifetherapeutic effectpulmonary function
NETL
NSTL
万方数据
